Gradient Investments’s Strata Critical Medical Inc SRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTA
AIM
NAMA
HVCM
NRCM
Gradient Investments's SRTA Position: Q2 2023 in Review
Gradient Investments sold out of Strata Critical Medical Inc (SRTA) in Q2 2023, closing a stake of 25 shares — an estimated $85 sold.
Gradient Investments first reported a position in SRTA in Q2 2022 and held it in 4 quarters. The position peaked at $90 in Q4 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q2 2023.
- Gradient Investments reported no remaining Strata Critical Medical Inc position as of Q2 2023 after selling out during the quarter.
- Gradient Investments sold 25 Strata Critical Medical Inc shares in Q2 2023, an estimated $85.
- Gradient Investments first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 4 quarters.
- Gradient Investments's Strata Critical Medical Inc position peaked at $90 in Q4 2022.
- 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2023.
Based on Gradient Investments's 13F filing for Q2 2023, filed 11 Jul 2023.